Pituitary surgery in Israel achieves success rates between 90% and 98% for tumor removal. Experts utilize minimally invasive transsphenoidal techniques to reach the skull base through the nasal cavity. These procedures result in visual improvement for approximately 93.5% of patients with preoperative vision loss.
- Hormonal recovery: Approximately 78% of patients with endocrine dysfunction regain normal hormonal function post-surgery.
- Total resection: Resection rates for non-functioning pituitary adenomas reach 84% at leading medical centers.
- Remission rates: Specialized centers report 85% to 95% remission for complex cases like Cushing's disease.
- Surgical safety: Major neurosurgical departments report 99% survival rates and low post-operative complication frequencies.
Bookimed Expert Insight: Data shows that top Israeli neurosurgeons often hold leadership roles in international bodies, such as Professor Zvi Ram heading the European Association of Neurosurgical Societies (EANS). This global involvement means patients at hospitals like Sourasky Medical Center receive care from doctors who shape international surgical protocols. Many leading specialists, including Dr. Strauss Ido and Dr. Grossman Rachel, also completed fellowships at premier North American institutions like Toronto Western and Johns Hopkins.
Patient Consensus: Patients often mention feeling much better quickly because surgeons use the nose to reach the tumor, avoiding visible scars. Many say their vision cleared up almost immediately after the procedure. They also note that Israeli teams are very thorough during pre-surgery MRI reviews to plan the best approach.
